IBER.WS
Ibere Pharmaceuticals Redeemable Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 per share
IBER.WS
IBER.WS
Delisted
IBER.WS was delisted on the 15th of February, 2023.
37 hedge funds and large institutions have $2.08M invested in Ibere Pharmaceuticals Redeemable Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 per share in 2022 Q2 according to their latest regulatory filings, with 6 funds opening new positions, 1 increasing their positions, 4 reducing their positions, and 2 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
less capital invested
Capital invested by funds: $ → $
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
Holders
37
Holding in Top 10
1
Calls
$2.22M
Puts
–
Top Buyers
| 1 | +$14K | |
| 2 | +$8K | |
| 3 | +$7.18K | |
| 4 |
AGM
Alpine Global Management
New York
|
+$5K |
| 5 |
SSA
Schonfeld Strategic Advisors
New York
|
+$4K |
Top Sellers
| 1 | -$24.3K | |
| 2 | -$5K | |
| 3 | -$1.17K | |
| 4 |
LCM
Lynwood Capital Management
Toronto,
Ontario, Canada
|
-$361 |